Marimed (MRMD) Long-Term Investments (2015 - 2024)

Marimed (MRMD) has 10 years of Long-Term Investments data on file, last reported at $274000.0 in Q1 2024.

• On a quarterly basis, Long-Term Investments changed N/A year-over-year to $274000.0 in Q1 2024; TTM through Mar 2024 was $274000.0, a N/A change from a year earlier, with the FY2023 full-year figure at $221000.0, changed N/A from the prior year.
• Long-Term Investments for Q1 2024 stood at $274000.0, up from $221000.0 in the prior quarter.
• Over the last five years, Long-Term Investments for MRMD reached as high as $2.1 million in Q3 2020 and fell as low as $89000.0 in Q2 2023.
• Historically, Long-Term Investments has averaged $882936.5 across 5 years, with a median of $1.0 million in 2020.
• Across the five-year window, Long-Term Investments tumbled 97.1% in 2020 and gained 16.06% in 2022, its largest moves.
• Year by year, Long-Term Investments stood at $1.2 million in 2020, then sank by 78.47% to $251000.0 in 2021, then surged by 439.04% to $1.4 million in 2022, then tumbled by 83.67% to $221000.0 in 2023, then advanced by 23.98% to $274000.0 in 2024.
• Per Business Quant data, the three most recent Long-Term Investments figures were $274000.0 in Q1 2024, $221000.0 in Q4 2023, and $164000.0 in Q3 2023.